2015
DOI: 10.1002/ccr3.244
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of chronic lymphocytic leukemia with bendamustine in an HIV‐infected patient on antiretroviral therapy: a case report and review of the literature

Abstract: Key Clinical MessageFew reports have described the coincidence of chronic lymphocytic leukemia (CLL) and HIV. We administered bendamustine to an HIV-positive refractory CLL patient and obtained a significant objective response. Our results indicate that bendamustine can be used in HIV-infected CLL patients. We also reviewed 12 cases of CLL with HIV infection.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
3
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…Similar low occurrences of concurrent HIV and CLL have been reported in other African populations. 4,30,40,41 In this study, HIV-positive CLL patients were aged ranging from 43 to 50 years, which is considerably lower than the mean age of 66.79 years at CLL diagnosis in the overall cohort. Notably, the differences in the ages of risk for HIV, a disease of younger people, 42 and for CLL, a disease of older people, could be possible factors behind the uncommon overlap between the two diseases.…”
Section: Human Immunodeficiency Virus Statusmentioning
confidence: 85%
“…Similar low occurrences of concurrent HIV and CLL have been reported in other African populations. 4,30,40,41 In this study, HIV-positive CLL patients were aged ranging from 43 to 50 years, which is considerably lower than the mean age of 66.79 years at CLL diagnosis in the overall cohort. Notably, the differences in the ages of risk for HIV, a disease of younger people, 42 and for CLL, a disease of older people, could be possible factors behind the uncommon overlap between the two diseases.…”
Section: Human Immunodeficiency Virus Statusmentioning
confidence: 85%